CNSP CNS Pharmaceuticals, Inc.

NASDAQ
$4.93

CNS Pharmaceuticals, Inc. (CNSP) is expected to report earnings on November 11, 2026, after the market close.

CNS Pharmaceuticals Reported Earnings
Wednesday, August 12, 2026 · 8:00 AM ET
Earnings Date
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is based in Houston, United States.

Sector

Healthcare

Charts powered in part by Lightweight Charts™ by TradingView.